Deal is predicated on pipeline, future prospects for renal disease and iron deficiency. Adjusted gross spread is 2.8%. Long GALN SW (there's FX risk, which can be hedged).
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.